logowsbdaily | Thu, 21 Oct 2021 07:34:38 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Atossa Therapeutics, Inc.
(ATOS)

Atossa Therapeutics, Inc.
107 Spring Street
Seattle, WA 98104
United States
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; AT-H201, a drug candidate to improve lung function in COVID-19 patients; and... Read More

Summary & Charts

Price$ 2.78-0.08 (-2.8%)
Day's Range$ 2.73 - 2.89 
Previous Close$ 2.86
Market Cap$ 205.4M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume4.72M
Avg. Volume (20 day)3.81M
Rel. Volume (20 day)1.24
Rel. Volume (3 month)0.63
RatingB+Buy
DCFN/AStrong Buy
Debt/Equity1.25 %Neutral
ROE-39.77 %Neutral
ROA-21.87 %Neutral
P/E-10.60 %Strong Sell
P/B2.35 %Strong Buy
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Oct 18, 2021$ 2.89$ 2.89$ 2.73$ 2.78-0.084,717,8561.240.632
Oct 15, 2021$ 2.93$ 3.03$ 2.86$ 2.86-0.054,735,7951.210.555
Oct 14, 2021$ 3.08$ 3.09$ 2.83$ 2.91-0.145,621,1371.360.624
Oct 13, 2021$ 3.02$ 3.08$ 2.98$ 3.05+0.023,033,6210.760.336
Oct 12, 2021$ 3.13$ 3.13$ 2.98$ 3.03-0.104,140,1370.990.4310
Oct 11, 2021$ 3.14$ 3.22$ 3.12$ 3.13-0.052,126,5520.500.215
Oct 08, 2021$ 3.27$ 3.33$ 3.16$ 3.18-0.092,280,1160.480.221
Oct 07, 2021$ 3.11$ 3.32$ 3.07$ 3.27+0.222,788,7780.530.231
Oct 06, 2021$ 3.06$ 3.14$ 3.04$ 3.05-0.052,656,7320.500.20
Oct 05, 2021$ 3.09$ 3.17$ 3.04$ 3.10+0.042,668,2330.500.19
Oct 04, 2021$ 3.19$ 3.20$ 3.03$ 3.06-0.193,189,2770.580.221
Oct 01, 2021$ 3.26$ 3.33$ 3.15$ 3.25-0.012,831,3430.500.201
Sep 30, 2021$ 3.15$ 3.30$ 3.11$ 3.26+0.116,266,5750.990.434
Sep 29, 2021$ 3.34$ 3.35$ 3.11$ 3.15-0.134,441,4340.680.302
Sep 28, 2021$ 3.38$ 3.44$ 3.24$ 3.28-0.175,128,7550.770.352
Sep 27, 2021$ 3.38$ 3.53$ 3.30$ 3.45+0.074,557,1060.680.304
Sep 24, 2021$ 3.41$ 3.48$ 3.34$ 3.38-0.134,003,2190.590.27
Sep 23, 2021$ 3.38$ 3.54$ 3.33$ 3.51+0.134,351,5310.640.292
Sep 22, 2021$ 3.33$ 3.42$ 3.25$ 3.38+0.104,144,2420.600.276
Sep 21, 2021$ 3.35$ 3.36$ 3.23$ 3.282,459,3760.350.167

News

The latest news about Atossa Therapeutics, Inc. (ATOS).

GlobeNewsWire | 2021-09-30 09:30:00
NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE NEBULIZED FORMULATION BEING DEVELOPED TO IMPROVE LUNG FUNCTION IN BOTH ACTIVE-DISEASE COVID-19 PATIENTS AND “LONG HAUL” PATIENTS WITH POST-INFECTION PULMONARY DISEASE
Seeking Alpha | 2021-09-22 14:27:22
Atossa Therapeutics is clinical-stage biotech whose stock has trended a highly volatile path during the last one-year period.
PennyStocks | 2021-09-21 16:20:40
Reddit penny stocks are here to stay; have you heard of these three? The post Hot Penny Stocks on Reddit to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2021-09-17 16:09:48
If you're looking for penny stocks on Reddit, check these three out first The post Top Penny Stocks on Reddit For Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2021-09-12 17:15:00
Making a penny stocks watchlist for this coming week? Check these 3 small-caps out The post 3 Hot Penny Stocks For This Week's Small-Caps Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace | 2021-09-10 13:47:38
Today, investors in Atossa Pharmaceuticals and ATOS stock appear to be cheering a delayed shareholder vote on a stock issuance proposal. The post ATOS Stock Holders Should Mark Their Calendars for Oct. 7 appeared first on InvestorPlace.
InvestorPlace | 2021-09-09 12:43:50
News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks. The post 7 Penny Stocks Waiting on The FDA for Rocket Fuel appeared first on InvestorPlace.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2021-11-11BMO-0.04----------
2021-08-13BMO------------
2021-05-14BMO-0.05-0.0420%------
2020-11-13BMO-0.34-0.34--------
2020-08-13BMO-0.28-0.4353.57%------
2020-05-13BMO-0.39-0.3217.95%------
2020-03-26BMO-0.33-0.2621.22%------
2019-11-13BMO-0.52-0.3630.77%------

Top Discussions

These are the top discussions over the last 24-hours that mention the ATOS stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Fri, 30 Jul 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.